131 related articles for article (PubMed ID: 11591022)
1. The efficiency and tolerance of half-body irradiation (HBI) in patients with multiple metastases. The Krakow experience.
Skolyszewski J; Sas-Korczynska B; Korzeniowski S; Reinfuss M
Strahlenther Onkol; 2001 Sep; 177(9):482-6. PubMed ID: 11591022
[TBL] [Abstract][Full Text] [Related]
2. Fractionated half-body irradiation (HBI) for the rapid palliation of widespread, symptomatic, metastatic bone disease: a randomized Phase III trial of the International Atomic Energy Agency (IAEA).
Salazar OM; Sandhu T; da Motta NW; Escutia MA; Lanzós-Gonzales E; Mouelle-Sone A; Moscol A; Zaharia M; Zaman S
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):765-75. PubMed ID: 11395246
[TBL] [Abstract][Full Text] [Related]
3. Single-dose half-body irradiation for palliation of multiple bone metastases from solid tumors. Final Radiation Therapy Oncology Group report.
Salazar OM; Rubin P; Hendrickson FR; Komaki R; Poulter C; Newall J; Asbell SO; Mohiuddin M; Van Ess J
Cancer; 1986 Jul; 58(1):29-36. PubMed ID: 2423225
[TBL] [Abstract][Full Text] [Related]
4. Fractionated half-body irradiation for pain palliation in widely metastatic cancers: comparison with single dose.
Salazar OM; DaMotta NW; Bridgman SM; Cardiges NM; Slawson RG
Int J Radiat Oncol Biol Phys; 1996 Aug; 36(1):49-60. PubMed ID: 8823258
[TBL] [Abstract][Full Text] [Related]
5. Half body irradiation of patients with multiple bone metastases: a phase II trial.
Berg RS; Yilmaz MK; Høyer M; Keldsen N; Nielsen OS; Ewertz M
Acta Oncol; 2009; 48(4):556-61. PubMed ID: 18979285
[TBL] [Abstract][Full Text] [Related]
6. A phase I/II study to evaluate the effect of fractionated hemibody irradiation in the treatment of osseous metastases--RTOG 88-22.
Scarantino CW; Caplan R; Rotman M; Coughlin C; Demas W; Delrowe J
Int J Radiat Oncol Biol Phys; 1996 Aug; 36(1):37-48. PubMed ID: 8823257
[TBL] [Abstract][Full Text] [Related]
7. Use of a modified hemi-body irradiation technique for metastatic carcinoma of the prostate: report of a 10-year experience.
Bashir FA; Parry JM; Windsor PM
Clin Oncol (R Coll Radiol); 2008 Oct; 20(8):591-8. PubMed ID: 18562185
[TBL] [Abstract][Full Text] [Related]
8. Once-a-week lower hemibody irradiation (HBI) for metastatic cancers.
Nag S; Shah V
Int J Radiat Oncol Biol Phys; 1986 Jun; 12(6):1003-5. PubMed ID: 2424877
[TBL] [Abstract][Full Text] [Related]
9. Palliation of bone metastases: a survey of patterns of practice among Canadian radiation oncologists.
Chow E; Danjoux C; Wong R; Szumacher E; Franssen E; Fung K; Finkelstein J; Andersson L; Connolly R
Radiother Oncol; 2000 Sep; 56(3):305-14. PubMed ID: 10974379
[TBL] [Abstract][Full Text] [Related]
10. Radiation therapy in the management of symptomatic bone metastases: the effect of total dose and histology on pain relief and response duration.
Arcangeli G; Giovinazzo G; Saracino B; D'Angelo L; Giannarelli D; Arcangeli G; Micheli A
Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):1119-26. PubMed ID: 9869238
[TBL] [Abstract][Full Text] [Related]
11. Radiotherapy for palliation of symptoms in incurable cancer.
Hoegler D
Curr Probl Cancer; 1997; 21(3):129-83. PubMed ID: 9202888
[TBL] [Abstract][Full Text] [Related]
12. Palliative hemibody irradiation in hormonally refractory metastatic prostate cancer.
Nseyo UO; Fontanesi J; Naftulin BN
Urology; 1989 Aug; 34(2):76-9. PubMed ID: 2474883
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of 3D-conformal half body irradiation in patients with multiple bone metastases.
Macchia G; Ferro M; Cilla S; Buwenge M; Ianiro A; Boccardi M; Picardi V; Ferro M; Arena E; Zamagni A; Cammelli S; Valentini V; Morganti AG; Deodato F
Clin Exp Metastasis; 2018 Dec; 35(8):747-752. PubMed ID: 30251079
[TBL] [Abstract][Full Text] [Related]
14. [Half-body irradiation. Palliative efficacy and predictive factors of response in 78 procedures].
Algara M; Valls A; Ruiz V; Jaume M; Lacruz M; Foro P
Med Clin (Barc); 1994 Jun; 103(3):85-8. PubMed ID: 8065222
[TBL] [Abstract][Full Text] [Related]
15. [Optimal doses and timing for tele-irradiation of bone metastases in patients with life expectancy more than 3 months].
Khmelevskiĭ EV; Pan'shin GA; Dobrovol'skaia NIu; Bol'shakova SA
Vopr Onkol; 2012; 58(3):380-6. PubMed ID: 22888655
[TBL] [Abstract][Full Text] [Related]
16. Palliation of bone metastases in prostate cancer. Hemibody irradiation or strontium-89?
Dearnaley DP; Bayly RJ; A'Hern RP; Gadd J; Zivanovic MM; Lewington VJ
Clin Oncol (R Coll Radiol); 1992 Mar; 4(2):101-7. PubMed ID: 1372817
[TBL] [Abstract][Full Text] [Related]
17. Half-body irradiation with tomotherapy for pain palliation in metastatic breast cancer.
Furlan C; Trovo M; Drigo A; Capra E; Trovo MG
J Pain Symptom Manage; 2014 Jan; 47(1):174-80. PubMed ID: 23796585
[TBL] [Abstract][Full Text] [Related]
18. Single-dose radiotherapy (6 Gy): palliation in painful bone metastases.
Uppelschoten JM; Wanders SL; de Jong JM
Radiother Oncol; 1995 Sep; 36(3):198-202. PubMed ID: 8532906
[TBL] [Abstract][Full Text] [Related]
19. Retrospective analysis of the effectiveness of volumetric modulated arc therapy half‑body irradiation in palliation of pain in patients with multiple bone metastases.
Kluska A; Tomasik B; Osadnik A; Tracz N; Trąbska-Kluch B; Matysiak P; Łuniewska-Bury J; Fijuth J; Gottwald L
Mol Clin Oncol; 2022 Nov; 17(5):153. PubMed ID: 36189106
[TBL] [Abstract][Full Text] [Related]
20. A report of RTOG 8206: a phase III study of whether the addition of single dose hemibody irradiation to standard fractionated local field irradiation is more effective than local field irradiation alone in the treatment of symptomatic osseous metastases.
Poulter CA; Cosmatos D; Rubin P; Urtasun R; Cooper JS; Kuske RR; Hornback N; Coughlin C; Weigensberg I; Rotman M
Int J Radiat Oncol Biol Phys; 1992; 23(1):207-14. PubMed ID: 1374061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
